Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | FPR2 | P25090 | 3/20 | 0.34 |
| ▸ | PROKR1 | Q8TCW9 | 3/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16262381 | 0.95 | EPHX1 (0.41) | SLC6A4EPHX1SLC6A2IDO1FPR2 | |
| Methyl Alcohol SCHEMBL8743765 | 0.80 | SLC6A4 (0.40) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL14672805 | 0.79 | SLC6A2 (0.41) | SLC6A4EPHX1SLC6A2IDO1SLC6A3 | |
| SCHEMBL16979030 | 0.73 | SLC6A4 (0.49) | SLC6A4SLC6A2IDO1FPR2PROKR1 | |
| SCHEMBL24369276 | 0.72 | PPM1B (0.31) | — | |
| SCHEMBL4598274 | 0.72 | SLC6A4 (0.47) | SLC6A4SLC6A2IDO1FPR2PROKR1 | |
| SCHEMBL11248115 | 0.72 | SLC6A4 (0.47) | SLC6A4SLC6A2IDO1FPR2PROKR1 | |
| SCHEMBL744402 | 0.72 | SLC6A4 (0.47) | SLC6A4EPHX1SLC6A2IDO1FPR2 | |
| SCHEMBL1134153 | 0.71 | — | — | |
| SCHEMBL19144912 | 0.71 | IDO1 (0.64) | SLC6A4EPHX1SLC6A2IDO1FPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4091578-B1 | METHOD FOR PRODUCING PLATE DENTURE | TOKUYAMA DENTAL CORP (JP) | 2024-10-09 | — | — | EP | disclosed |
| US-11857385-B2 | Method of producing plate denture, curable composition for stereolithography, and plate denture production kit | TOKUYAMA DENTAL CORPORATION (JP) | 2024-01-02 | — | — | US | disclosed |
| US-20230320940-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION AND DENTAL CURABLE COMPOSITION | TOKUYAMA DENTAL CORPORATION (JP) | 2023-10-12 | — | — | US | disclosed |
| EP-4194477-A1 | PHOTOCATIONIC CURABLE COMPOSITION AND CURABLE DENTAL COMPOSITION | Tokuyama Dental Corporation (JP) | 2023-06-14 | — | — | EP | disclosed |
| US-20230137898-A1 | METHOD OF PRODUCING PLATE DENTURE, CURABLE COMPOSITION FOR STEREOLITHOGRAPHY, AND PLATE DENTURE PRODUCTION KIT | TOKUYAMA DENTAL CORPORATION (JP) | 2023-05-04 | — | — | US | disclosed |
| EP-4091578-A1 | METHOD FOR PRODUCING PLATE DENTURE, CURABLE STEREOLITHOGRAPHIC COMPOSITION, AND PLATE DENTURE PRODUCTION KIT | Tokuyama Dental Corporation (JP) | 2022-11-23 | — | — | EP | disclosed |
| US-8900775-B2 | Hologram recording material and hologram recording medium | TDK CORPORATION (JP) | 2014-12-02 | — | — | US | disclosed |
| US-20130034805-A1 | HOLOGRAM RECORDING MATERIAL AND HOLOGRAM RECORDING MEDIUM | TDK CORPORATION (JP) | 2013-02-07 | — | — | US | disclosed |
| EP-1591098-B1 | Cationically curable composition for dental use | TOKUYAMA CORP (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-7365106-B2 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2008-04-29 | — | — | US | disclosed |
| US-20050250868-A1 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2005-11-10 | — | — | US | disclosed |
| EP-1591098-A1 | Cationically curable composition for dental use | TOKUYAMA CORPORATION (JP) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320940-A1 | PHOTOCATIONICALLY CURABLE COMPOSITION AND DENTAL CURABLE COMPOSITION | CTH, GCLC, AAAS | SLC6A4 2943/4885EPHX1 1529/4885SLC6A2 3983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.